Platelet aggregation in feline cardiomyopathy

Area of Science:

• Veterinary Medicine
• Hematology
• Cardiology

Background:

• Platelet aggregation plays a crucial role in hemostasis and thrombosis.
• Cardiomyopathy in cats can lead to complex physiological changes, potentially affecting blood components.
• Understanding platelet behavior is vital for diagnosing and managing cardiovascular diseases in felines.

Purpose of the Study:

• To investigate platelet aggregation response to adenosine diphosphate (ADP) in cats with cardiomyopathy.
• To determine the minimum ADP threshold concentration for irreversible platelet aggregation in healthy and affected cats.
• To explore potential correlations between platelet count and aggregation response in feline cardiomyopathy.

Main Methods:

• Evaluated platelet aggregation in 16 healthy cats and 10 cats with cardiomyopathy.
• Determined the minimum ADP concentration inducing irreversible (2nd-phase) aggregation for each cat.
• Measured platelet counts and analyzed aggregation curve parameters (lag phase, slope).

Main Results:

• Cats with cardiomyopathy showed significantly lower ADP thresholds for platelet aggregation (0.01–10 microM) compared to healthy cats (1–100 microM).
• 56% of healthy cats required 100 microM ADP for aggregation, while affected cats responded to much lower concentrations.
• No correlation was found between platelet count and the magnitude of the aggregation response.

Conclusions:

• Platelets from some cats with cardiomyopathy are hyperaggregable to ADP in vitro.
• Altered platelet function may be a contributing factor or consequence of cardiomyopathy in cats.
• Further research is warranted to elucidate the clinical implications of platelet hyperaggregability in feline heart disease.